PRADAXA 150MG 30CAP; dabigatran, cardiovascular agents .
ACTIVE-INGREDIENT OF PRADAXA 150MG 30CAP
the active substance is dabigatran , which is administered in the form of 150 mg dabigatran etexilate given as mesilate .
INDICATION OF PRADAXA 150MG 30CAP
pradaxa is a medicine which is used to reduce the risk of brain or body vessel obstruction by blood clot formation in adult patients with an abnormal heart beat ( arterial fibrillation ) and additional risk factors . Pradaxa is a blood thinner medicine that lowers the risk of blood clot formation . pradaxa is a medicine which is used to treat blood clots in the veins of your legs and lungs and to prevent blood clots from re-occuring in the vein of your legs and lungs .
DOSAGE OF PRADAXA 150MG 30CAP
Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet
Ask your pharmacist or doctor for help if you do not understand the instructions on the box .
The recommended dose is : –
always take this medicine exactly as your doctor has told you . Check with your doctor if you are not sure . The recommended dose is 300 mg taken as one 150 mg capsule twice a day . If you are 80 years or older , the recommended dose of pradaxa is 220 mg taken as one 110 mg capsule twice daily . if you are taking verapamil – containing medicines , you should be treated with a reduced pradaxa dose of 220 mg taken as one 110 mg capsule twice a day , because your bleeding risk may be increased , if you have a potentially higher risk for bleeding , your doctor may decide to prescribe dose of pradaxa 220 mg taken as one 110 mg capsule twice a day . pradaxa can be taken with or without food . the capsule should be swaalowed whole with a glass of water to ensure delivery to the stomach . do not break , chew , or empty the pellets from the capsule since this may increase the risk of bleeding . when taking pradaxa capsules out of the blister pack please observe the following instructions : talke the capsules by peeling off the backing foil of the blister card . do not push the capsules through the blister foil . do not peel off the blister foil until a capsule is required . change of anticoagulant treatment : changing from treatment with pradaxa to anticoagulant treatment given by injection : do not start treatment given by injectable anticoagulant medicines ( for example , heparin ) until 12 hours after the final dose of pradaxa . changing from anticoagulant treatment given by injection to treatment with pradaxa : start taking pradaxa 0-2 hours before the time you would havbe had the next injection . changing from pradaxa to blood thinners containing vitamin – k antagonists (e.g. phenprocoumon ) : your doctor needs to do blood – meaasurements and instruct you when to start vitamin – k antagonist treatment . changing from blood thinners containing vitamin – k antagonists ( e.g. phenprocoumon ) to pradaxa : stop taking the medicine containing a vitamin -k antagonist . your doctor needs to do blood – measurements and instruct you when to start pradaxa treatment .
OVER-DOSAGE OF PRADAXA 150MG 30CAP
if you take more pradaxa than recommended , you may have an increased risk of bleeding . Your doctor can perform a blood test to assess the risk of bleeding . Inform your doctor immediately , if you take more than the prescribed dose of pradaxa . If bleeding occurs , surgical treatment or treatmernt with blood transfusions may be required .
CONTRA-INDICATION OF PRADAXA 150MG 30CAP
do not take pradaxa : if you are allergic to dabigatran or any of the other ingerdients of this medicine . If you have severly reduced kidney function . If you are currently bleeding . If you have a disease in an organ of the body that increases the risk of serious bleeding . if you have an increased tendency to bleed . this nmay be inborn , of unknown cause or due to other medicines . if you have a severely reduced liver function or liver disease which could possibly cause death . if you are taking oral ketoconazole or itraconzole , medicines to treat fungal infections . if you are taking cyclosporine , a medicine to prevent organ rejection after transoplantation . if you are taking dronedarone , a medicine used to prevent repetition of your problem or irregular heart beat . if you are taking medicines to prevent blood clotting ( e.g. warfarin , rivaroxaban , apixaban or heparin ) , except when changing anticoagulant treatment or while having a venous or arterial line and you get heparin throught this line to keep it open . if you have received an artificial heart valve .
STORAGE OF PRADAXA 150MG 30CAP
store below 30 C , in the ioriginal package in order to protect from moisure .
PACK OF PRADAXA 150MG 30CAP
pradaxa 150 mg hard capsules are available in packs containing 10 ( 10’s blister X 1 ) , 30 ( 10’s blister X 3 ) , 60 ( 10’s blister X 6 ) a multipack containing 3 packs of 60 hard capsules (180 hard capsules ) or a multipack containing 2 packs of 50 hard capsules ( 100 hard capsules ) in aluminium perforated unit dose blisters . not all pack sizes may be marketed .
PRADAXA 150MG 30CAP MANUFACTURED BY
Boehringer Ingelheim Pharma GmbH & Co . KG Binger streasse 173 55216 Ingelheim am Rhein Germany .